書誌事項
- タイトル別名
-
- Clinical Study of Levofloxacin (LVFX) 400 mg Orally in Two Divided Portions for Acute Exacerbation of Chronic Otitis Media and Chronic Sinusitis
- ヤクブツ チュウジエン オヨビ フクビクウエン ニ タイスル LVFX クラビット ノ コウカ 1ニチ 400mg ブン 2 トウヨ ノ ユウヨウセイ
- 1日400mg分2投与の有用性
この論文をさがす
説明
Twenty-six adult cases of acute exacerbation of chronic otitis media (COM) and twenty cases of acute exacerbation of chronic sinusitis (CS) were treated by Levofloxacin (LVFX) 400mg a day in two divided portions. The clinical efficacy rates were 84.6% for COM and 85% for CS. Bacteriolgical therapeutic failures in treatment were observed in four COM and three CS patients. Adverse response and abnormal laboratory findings were not observed. LVFX was more effective when given at 400mg a day in two divided portions.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 99 (2), 151-156, 2006
耳鼻咽喉科臨床学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679241680512
-
- NII論文ID
- 130001816961
- 10017161708
-
- NII書誌ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL書誌ID
- 7817293
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可
